Lorelei M. Skillman - Jan 5, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Mrktg. & Comm. Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 04:40 PM
Previous filing
Oct 27, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +4.52K +10.03% $0.00 49.6K Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENFN Stock Option (Right to Buy) Award $0 +7.47K $0.00 7.47K Jan 5, 2023 Class A Common Stock 7.47K $11.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 1,507, 1,507, 1,507 RSUs will vest on January 5, 2024, January 5, 2025, and January 5, 2026, respectively.
F2 These options were granted under the Plan and shall become exercisable as follows: 2,492, 2,491, and 2,491 on January 5, 2024, January 5, 2025, and January 5, 2026, respectively.

Remarks:

Exhibit 24 - Power of Attorney